Vir Biotechnology, Inc.
← Back to VIR Overview

Vir Biotechnology, Inc. (VIR)

Solvency & Capital Structure

Total Debt

$95.6M

Net Debt

-$376.8M

Vir Biotechnology, Inc. currently has $95.6M in total debt. Net debt is -$376.8M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

VIRQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-03-310.100.47-0.38Net Cash1.039.3%
2025-12-310.190.46-0.28Net Cash1.0018.6%
2025-09-300.100.51-0.41Net Cash1.029.8%
2025-06-300.100.61-0.50Net Cash1.198.6%
2025-03-310.100.80-0.71Net Cash1.317.3%
2024-12-310.100.91-0.81Net Cash1.407.0%
2024-09-300.110.91-0.80Net Cash1.507.5%
2024-06-300.111.15-1.04Net Cash1.676.9%
2024-03-310.121.15-1.03Net Cash1.796.7%
2023-12-310.121.52-1.40Net Cash1.926.5%
2023-09-300.131.70-1.57Net Cash2.046.2%
2023-06-300.131.85-1.72Net Cash2.245.9%
2023-03-310.132.25-2.12Net Cash2.674.8%
2022-12-310.132.40-2.27Net Cash2.804.6%
2022-09-300.132.35-2.22Net Cash2.704.9%
2022-06-300.132.20-2.06Net Cash2.625.1%
2022-03-310.141.26-1.12Net Cash2.894.7%
2021-12-310.140.71-0.57Net Cash1.957.0%
2021-09-300.070.94-0.87Net Cash1.216.0%
2021-06-300.070.83-0.75Net Cash1.066.9%
2021-03-310.070.73-0.66Net Cash1.146.2%
2020-12-310.070.74-0.67Net Cash0.927.6%
2020-09-300.020.83-0.81Net Cash0.941.7%
2020-06-300.020.55-0.54Net Cash0.672.4%
2020-03-310.020.36-0.34Net Cash0.483.5%
2019-12-310.000.38-0.38Net Cash0.510.0%
2019-09-300.000.32-0.32Net Cash0.420.3%
2019-06-300.000.36-0.36Net Cash0.460.0%
2019-03-310.000.10-0.10Net Cash0.00
2018-12-310.010.10-0.09Net Cash0.195.3%
2018-03-310.000.19-0.19Net Cash0.00